Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
The Clinical Journal of Pain|December 21, 2006
An interdisciplinary expert consensus statement on assessment of pain in older personsThomas Hadjistavropoulos, Keela Herr, Dennis C Turk, et al.Cell|December 14, 2011
The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assemblyJorge Z Torres, Matthew K Summers, David Peterson, et al.The Journal of Pain|May 1, 2010
Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-baseC Richard Chapman, David L Lipschitz, Martin S Angst, et al.Journal of Alternative and Complementary Medicine (New York, N.Y.)|December 1, 2007
Response to a proposal for an integrative medicine curriculumPatricia J Benjamin, Reed Phillips, Don Warren, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2013
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression StudyDavid Peterson, Caitlin Munger, Jared Crowley, et al.Cancer Research|November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancerMark L McCleland, Adam S Adler, Yonglei Shang, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.Cell Metabolism|July 26, 2018
Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell StateAnneleen Daemen, Bonnie Liu, Kyung Song, et al.Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitorsAnneleen Daemen, David Peterson, Nisebita Sahu, et al.Bioorganic & Medicinal Chemistry Letters|September 10, 2013
Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenaseBenjamin P Fauber, Peter S Dragovich, Jinhua Chen, et al.Pageof 13